Article

bizjournals.com on 2017-12-15 14:17

Aclaris' treatment for common skin condition gets FDA OK

FDA

Related news

Chesco gene therapy company seeks FDA OK to begin human testing of skin disorder treatment bizjournals.com
West Chester pharma firm to seek FDA OK for skin treatment bizjournals.com
West Chester
Warts and all — Malvern firm testing potential treatment for common skin condition bizjournals.com
United States , Chester , Great Malvern
TFDA Approves the First “Spray-on-Skin”torchonline.com
DSkin Lightening Pills Not Approved – FDA dailyguideafrica.com
The Head , Bolgatanga , Ghana
PFDA OKs Amgen skin cancer drug Imlygic pacbiztimes.com
TSkin-Lightening Products Popular Despite FDA Warnings today.uconn.edu
Genetic-test service back with FDA OK Arkansas Online
Mountain View , Silicon Valley , San Francisco
OK entrepreneur’s medical device wins FDA approval journalrecord.com
Oklahoma City
FDA: Genetically engineered salmon OK to eat The Columbian
Chinook , Pacific Ocean , Panama , Canada , Alaska
FDA OK's Odomza from Novartis for common skin cancer type abc3340.com
Indian Springs , Broken Arrow , Tulsa , Indiana , Michigan City
FDA OK's Odomzo from Novartis for common skin cancer type dothaneagle.com
New Jersey , East Hanover , Switzerland
FDA OK’s Odomza from Novartis for common skin cancer type wkrg.com
New Jersey , East Hanover , Switzerland
FDA OK’s Odomzo from Novartis for common skin cancer type The Findlay Courier
New Jersey , East Hanover , Switzerland
FDA approves Regeneron, Sanofi skin cancer immuno-oncology drug westfaironline.com
France , Tarrytown
EMD Serono nabs FDA approval for rare skin cancer drug bizjournals.com
Thermometers recalled due to reports of 'severe skin burns': FDA New York Post
Walnut Creek